The interaction of dietary supplements with antithrombotic agents: Scope of the problem

Thrombosis Research

Volumn 117, Issue 1-2, 2005, Pages 7-13

  Marder, Victor J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMINO ACID; ANABOLIC AGENT; ANGELICA SINENSIS EXTRACT; ANTICOAGULANT AGENT; BARBITURIC ACID DERIVATIVE; CHLORAL HYDRATE; CLOFIBRATE; CORTICOSTEROID; COSMETIC; GINSENG EXTRACT; GLUCAGON; GLUTETHIMIDE; GREEN TEA EXTRACT; GRISEOFULVIN; HALOPERIDOL; HERBACEOUS AGENT; METRONIDAZOLE; MINERAL; NEOMYCIN; ORAL CONTRACEPTIVE AGENT; PAPAIN; SALVIA MILTIORRHIZA EXTRACT; UBIDECARENONE; UNINDEXED DRUG; VACCINE; VITAMIN; VITAMIN K GROUP; WARFARIN;

BLEEDING; BLOOD CLOT LYSIS; CHEMICAL INTERACTION; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; HEALTH EDUCATION; HEALTH PRACTITIONER; HEMOSTASIS; HERB DRUG INTERACTION; HERBAL MEDICINE; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; STROKE; THROMBOEMBOLISM; THROMBOSIS;

ANIMALS; BLOOD COAGULATION; CLINICAL TRIALS; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; FOOD-DRUG INTERACTIONS; HEMORRHAGE; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 27744459001     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.05.023     Document Type: Conference Paper

References (30)

1. W.D. Rosamond, L.E. Chambless, A.R. Folsom, L.S. Cooper, D.E. Conwill, and L. Clegg Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994 N Engl J Med 339 1998 861 867
2. American Heart Association 1999 heart and stroke statistical update 1999 American Heart Association Dallas, Tex.
3. M.D. Silverstein, J.A. Heit, D.N. Mohr, T.M. Peterson, W.M. O'Fallen, and J. Melton Trends in the incidence of deep vein thrombosis and pulmonary embolism Arch Intern Med 158 1998 585 593
4. D.M. Eisenberg, R.B. Davis, S.L. Ettner, S. Appel, S. Wilkey, and M. Van Rompay Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey JAMA 280 1998 1569 1575
5. C.L. Norred Complementary and alternative medicine use by surgical patients AORN J 76 2002 1013 1021
6. S.C. Collins, and R.G. Dufresne Jr. Dietary supplements in the setting of mohs surgery Dermatol Surg 28 2002 447 452
7. A.A. Izzo, and E. Ernst Interactions between herbal medicines and prescribed drugs: a systematic review Drugs 61 2001 2163 2175
8. A.K. Wittkowsky Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions Semin Vasc Med 3 2003 221 230
9. S.C. Smolinske Dietary supplement-drug interactions J Am Med Womens Assoc 54 1999 191 192
10. R. Sabar, A.D. Kaye, and E.A. Frost Perioperative considerations for the patient taking herbal medicines Heart Dis 3 2001 87 96
11. R.C. Kessler, R.B. Davis, D.F. Foster, M.I. Van Rompay, E.E. Walters, and S.A. Wilkey Long-term trends in the use of complementary and alternative medical therapies in the United States Ann Intern Med 135 2001 262 268
12. S.M. Huang, S.D. Hall, P. Watkins, L.A. Love, C. Serabjit-Singh, and J.M. Betz Drug interactions with herbal products and grapefruit juice: a conference report Clin Pharmacol Ther 75 2004 1 12
13. D.M. Marcus, and A.P. Grollman Botanical medicines - the need for new regulations N Engl J Med 347 2002 2073 2075
14. U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition Dietary supplement and education act of 1994 Available from: http://www.cfsan.fda.gov/∼dms/dietsupplhtml 2005 Accessed March
15. F.A. Hoffman Regulation of dietary supplements in the United States: understanding the dietary supplement health and education act Clin Obstet Gynecol 44 2001 780 788
16. S.M. Wolfe Ephedra - scientific evidence versus money/politics Science 300 2003 437
17. S. Bondurant Mainstream and alternative medicine: converging paths require common standards Ann Intern Med 142 2005 149 150
18. P.A.G.M. De Smet Herbal remedies N Engl J Med 347 2002 2046 2056
19. D. Heber Foreward in PDR for herbal medicines Third Edition 2004 Thomson PDR Montvale, NJ
20. R.L. Mueller First-generation agents: aspirin, heparin and coumarins Baillière's Best Pract Res Clin Haematol 17 2004 23 53
21. E. Stone An account of the success of the bark of the willow in the cure of agues Philos Trans R Soc Lond (Biology) 53 1763 195 200
22. H.J. Weiss, L.M. Aledort, and S. Kochwa The effect of salicylates on the hemostatic properties of platelets in man J Clin Invest 47 1968 2169 2180
23. J.R. Vane Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nature 231 1971 232 235
24. H.A. Campbell, W.L. Roberts, W.K. Smith, and K.P. Link Studies of the hemorrhagic sweet clover disease: I. The preparation of hemorrhagic concentrates J Biol Chem 136 1940 47 55
25. H. Dam Antihemorrhagic vitamin of the chick: occurrence and chemical nature Nature 135 1935 652 653
26. T.E. Warkentin Bivalent direct thrombin inhibitors: hirudin and bivalirudin Baillière's Best Pract Res Clin Haematol 17 2004 105 125
27. G. Haas Versuche der blutauswaschung am lebenden mit hilfe der dialyse Klin Wochenschr 4 1925 13 14
28. M.M. Wintrobe, G.R. Lee, D.R. Boggs, T.C. Bithell, J. Foerster, and J.W. Athens Clinical hematology 1981 Lea & Febiger Philadelphia
29. M.K. Ang-Lee, J. Moss, and C.-S. Yuan Herbal medicines and perioperative care JAMA 286 2001 208 216
30. C.-S. Yuan, G. Wei, L. Dey, T. Karrison, L. Nahlik, and S. Maleckar Brief communication: American ginseng reduces warfarin's effect in healthy patients Ann Intern Med 141 2004 23 27